Men And Women – Erectile dysfunction / Impotence

FDA on June, 18th will consider a question on the statement a preparation, which will be the first to improve sex desire of the woman. Now women have very few variants, when it is a question to help them from their sex life. Really, FDA not to approve yet any medicines which prescribe for treatment, or improvement, sex experience of the woman.

Many news articles concern to Flibanserin as “female viagra” or “pink Viagra”. Actually, however, Flibanserin works in such a manner that it is even not similar to viagra. Flibanserin works for augmentation or reduction of some chemical substances in a brain (a serotonin, Dofaminum and Noradrenalinum), thereby enlarging desire of the woman for sex. Viagra is PDE-5 an inhibitor, which works to enlarge a blood flow – in this case, to a penis.

There are a few disputes around Flibanserin. The first factor is efficiency of a product. More than 5000 women have taken part in clinical tests Flibanserin, and number of satisfaction of sex experience that they in a month has increased with 2,7 to 4,5 (against 3,7 with placebo).

Some critics tell these digits are not significant, and women in researches declares that the preparation gives the big difference. Some critics also has declared that the pharmaceutical industry, in its mission on sale of narcotics, exaggerates prevalence, and even existence. This condition is defined as inexplicable loss of sex thoughts, imaginations and desires. Some researches show, 10 percent of women can suffer from HSDD, which many in the field of call medicine valid disorders which can be very emotionally distressful and disappointment of a condition for women.

Any serious or harmful by-effects have been found by means of Flibanserin, and the most widespread by-effects are included drowsiness, giddiness and a nausea. The majority of by-effects has left after treatment continuation.

Germany Boehringer Ingelheim has developed Flibanserin, narcotics that some speak can generate as very much as $2 billion in one only the United States.

Familiarise with additional pharmaceutical news on blog AccessRx.

Also see section AccessRx of news to additional articles on numerous questions of public health services.